474 related articles for article (PubMed ID: 32336666)
21. Neu-164 and Neu-107, two novel antioxidant and anti-myeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammation.
Thatcher TH; Hsiao HM; Pinner E; Laudon M; Pollock SJ; Sime PJ; Phipps RP
Am J Physiol Lung Cell Mol Physiol; 2013 Jul; 305(2):L165-74. PubMed ID: 23686858
[TBL] [Abstract][Full Text] [Related]
22. Glutathione peroxidase-1 as a novel therapeutic target for COPD.
Vlahos R; Bozinovski S
Redox Rep; 2013; 18(4):142-9. PubMed ID: 23849338
[TBL] [Abstract][Full Text] [Related]
23. Vitamin E isoform γ-tocotrienol protects against emphysema in cigarette smoke-induced COPD.
Peh HY; Tan WSD; Chan TK; Pow CW; Foster PS; Wong WSF
Free Radic Biol Med; 2017 Sep; 110():332-344. PubMed ID: 28684161
[TBL] [Abstract][Full Text] [Related]
24. Effect of allyl isothiocyanate on oxidative stress in COPD via the AhR / CYP1A1 and Nrf2 / NQO1 pathways and the underlying mechanism.
Zhu WT; Li CH; Dai TT; Song QQ; Chen Y; Han ZL; Sun NX; Wang DL
Phytomedicine; 2023 Jun; 114():154774. PubMed ID: 36996530
[TBL] [Abstract][Full Text] [Related]
25. Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease.
Wiegman CH; Li F; Ryffel B; Togbe D; Chung KF
Front Immunol; 2020; 11():1957. PubMed ID: 32983127
[TBL] [Abstract][Full Text] [Related]
26. Oxidants and COPD.
MacNee W
Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):627-41. PubMed ID: 17305519
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
Kirkham P; Rahman I
Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress in COPD.
Kirkham PA; Barnes PJ
Chest; 2013 Jul; 144(1):266-273. PubMed ID: 23880677
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress in patients with COPD.
Loukides S; Bakakos P; Kostikas K
Curr Drug Targets; 2011 Apr; 12(4):469-77. PubMed ID: 21194408
[TBL] [Abstract][Full Text] [Related]
32. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
Lin JL; Thomas PS
COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
[TBL] [Abstract][Full Text] [Related]
33. Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells.
Pace E; Ferraro M; Di Vincenzo S; Cipollina C; Gerbino S; Cigna D; Caputo V; Balsamo R; Lanata L; Gjomarkaj M
Cell Stress Chaperones; 2013 Nov; 18(6):733-43. PubMed ID: 23580157
[TBL] [Abstract][Full Text] [Related]
34. Oxidation pathway and exacerbations in COPD: the role of NAC.
Matera MG; Calzetta L; Cazzola M
Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
[TBL] [Abstract][Full Text] [Related]
35. Curcumin attenuates skeletal muscle mitochondrial impairment in COPD rats: PGC-1α/SIRT3 pathway involved.
Zhang M; Tang J; Li Y; Xie Y; Shan H; Chen M; Zhang J; Yang X; Zhang Q; Yang X
Chem Biol Interact; 2017 Nov; 277():168-175. PubMed ID: 28951138
[TBL] [Abstract][Full Text] [Related]
36. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
MacNee W
Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.
Wiegman CH; Michaeloudes C; Haji G; Narang P; Clarke CJ; Russell KE; Bao W; Pavlidis S; Barnes PJ; Kanerva J; Bittner A; Rao N; Murphy MP; Kirkham PA; Chung KF; Adcock IM;
J Allergy Clin Immunol; 2015 Sep; 136(3):769-80. PubMed ID: 25828268
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress and redox regulation of lung inflammation in COPD.
Rahman I; Adcock IM
Eur Respir J; 2006 Jul; 28(1):219-42. PubMed ID: 16816350
[TBL] [Abstract][Full Text] [Related]
39. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
40. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
